7235.   Akuta N, Suzuki F, Tsubota A, Suzuki Y, Hosaka T, Someya T, Kobayashi M, Saitoh S, Arase Y, Ikeda K, Kumada H.  Association of amino acid substitution pattern in nonstructural protein 5A of hepatitis C virus genotype2a low viral load and response to interferon monotherapy. J Med Virol. 2003 Mar;69(3):376-83.

7236.   Alter MJ, Kuhnert WL, Finelli L.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2003 Feb 7;52(RR-3):1-13, 15; quiz CE1-4.

7237.   Arguedas MR, Chen VK, Eloubeidi MA, Fallon MB.   Screening for hepatocellular carcinoma in patients with hepatitis C cirrhosis: a cost-utility analysis. Am J Gastroenterol. 2003 Mar;98(3):679-90.

7238.   Bandi L.  Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked. Postgrad Med. 2003 Feb;113(2):73-6, 86.

7239.   Barrett S, Ryan E, Crowe J.  Serum versus intrahepatic HCV RNA and liver histology in anti-HCV-positive serum PCR-negative individuals. Hepatology. 2003 Jan;37(1):223-4.

7240.   Baughman RP, Koehler A, Bejarano PA, Lower EE, Weber FL Jr.  Role of liver function tests in detecting methotrexate-induced liver damage in sarcoidosis. Arch Intern Med. 2003 Mar 10;163(5):615-20.

7241.   Berg T, Sarrazin C, Herrmann E, Hinrichsen H, Gerlach T, Zachoval R, Wiedenmann B, Hopf U, Zeuzem S.   Prediction of treatment outcome in patients with chronic hepatitis C: significance of baseline parameters and viral dynamics during therapy. Hepatology. 2003 Mar;37(3):600-9.

7242.   Bortolotti F, Muratori L, Jara P, Hierro L, Verucchi G, Giacchino R, Barbera C, Zancan L, Guido M, Resti M, Pedditzi S, Bianchi F, Gatta A.  Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children. J Pediatr. 2003 Feb;142(2):185-90.

7243.   Caturelli E, Castellano L, Fusilli S, Palmentieri B, Niro GA, del Vecchio-Blanco C, Andriulli A, de Sio I.   Coarse nodular US pattern in hepatic cirrhosis: risk for hepatocellular carcinoma. Radiology. 2003 Mar;226(3):691-7.

7244.   Cauza E, Peck-Radosavljevic M, Ulrich-Pur H, Datz C, Gschwantler M, Schoniger-Hekele M, Hackl F, Polli C, Rasoul-Rockenschaub S, Muller C, Wrba F, Gangl A, Ferenci P.  Mutations of the HFE gene in patients with hepatocellular carcinoma. Am J Gastroenterol. 2003 Feb;98(2):442-7.

7245.   Chalasani N, Gorski JC, Asghar MS, Asghar A, Foresman B, Hall SD, Crabb DW.  Hepatic cytochrome P450 2E1 activity in nondiabetic patients with nonalcoholic steatohepatitis. Hepatology. 2003 Mar;37(3):544-50.

7246.   Chiu HF, Chih TT, Hsian YM, Tseng CH, Wu MJ, Wu YC.  Bullatacin, a potent antitumor Annonaceous acetogenin, induces apoptosis through a reduction of intracellular cAMP and cGMP levels in human hepatoma 2.2.15 cells. Biochem Pharmacol. 2003 Feb 1;65(3):319-27.

7247.   Daveau M, Scotte M, Francois A, Coulouarn C, Ros G, Tallet Y, Hiron M, Hellot MF, Salier JP.   Hepatocyte growth factor, transforming growth factor alpha, and their receptors as combined markers of prognosis in hepatocellular carcinoma. Mol Carcinog. 2003 Mar;36(3):130-41.

7248.   De Rosa FG, Bonora S, Di Perri G.  Healthy ranges for alanine aminotransferase levels. Ann Intern Med. 2003 Jan 21;138(2):156-7

7249.   Dufour DR, Talastas M, Fernandez MD, Harris B, Strader DB, Seeff LB.  Low-positive anti-hepatitis C virus enzyme immunoassay results: an important predictor of low likelihood of hepatitis C infection. Clin Chem. 2003 Mar;49(3):479-86.

7250.   Fabris P, Tositti G, Giordani MT, Romano L, Betterle C, Pignattari E, Tagliaferri C, Muratori P, Manfrin V, de Lalla F. Prevalence and clinical significance of circulating cryoglobulins in HIV-positive patients with and without co-infection with hepatitis C virus. J Med Virol. 2003 Mar;69(3):339-43.

7251.   Fujita N, Kaito M, Takeo M, Iwasa M, Ikoma J, Watanabe S, Adachi Y. Nonimmune complexed HCV RNA titer in serum as a predictor of interferon response in patients with chronic hepatitis C.Am J Gastroenterol. 2003 Mar;98(3):645-52.

7252.   Giannini E, Risso D, Botta F, Chiarbonello B, Fasoli A, Malfatti F, Romagnoli P, Testa E, Ceppa P, Testa R.  Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease.Arch Intern Med. 2003 Jan 27;163(2):218-24.

7253.   Jayshree RS, Sridhar H, Devi GM. Surface, core, and X genes of hepatitis B virus in hepatocellular carcinoma: an in situ hybridization study. Cancer. 2003 Feb 25;99(1):63-7.

7254.   Jinushi M, Takehara T, Kanto T, Tatsumi T, Groh V, Spies T, Miyagi T, Suzuki T, Sasaki Y, Hayashi N.   Critical role of MHC class I-related chain A and B expression on IFN-alpha-stimulated dendritic cells in NK cell activation: impairment in  chronic hepatitis C virus infection. J Immunol. 2003 Feb 1;170(3):1249-56.

7255.   Kien F, Abraham JD, Schuster C, Kieny MP.  Analysis of the subcellular localization of hepatitis C virus E2 glycoprotein in live cells using EGFP fusion proteins. J Gen Virol. 2003 Mar;84(Pt 3):561-6.

7256.   Levine PH, Delgado Y, Theise ND, West AB.  Stellate-cell lipidosis in liver biopsy specimens. Recognition and significance. Am J Clin Pathol. 2003 Feb;119(2):254-8.

7257.   Ma CL, Fang DX, Chen HB, Li FQ, Jin HY, Li SQ, Tan WG.  A mutation specific polymerase chain reaction for detecting hepatitis B virus genome mutations at nt551. World J Gastroenterol. 2003 Mar;9(3):509-12.

7258.   Matsukura S, Soejima H, Nakagawachi T, Yakushiji H, Ogawa A, Fukuhara M, Miyazaki K, Nakabeppu Y, Sekiguchi M, Mukai T.   CpG methylation of MGMT and hMLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection. Br J Cancer. 2003 Feb 24;88(4):521-9.

7259.   Myers RP, De Torres M, Imbert-Bismut F, Ratziu V, Charlotte F, Poynard T.  Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index. Dig Dis Sci. 2003 Jan;48(1):146-53.

7260.   Rossi E, Adams L, Prins A, Bulsara M, de Boer B, Garas G, MacQuillan G, Speers D, Jeffrey G.   Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem. 2003 Mar;49(3):450-4.

7261.   Ruhl CE, Everhart JE.  Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003 Jan;124(1):71-9.

7262.   Sedlaczek N, Hasilik A, Neuhaus P, Schuppan D, Herbst H.  Focal overexpression of insulin-like growth factor 2 by hepatocytes and cholangiocytes in viral liver cirrhosis. Br J Cancer. 2003 Mar 10;88(5):733-9.

7263.   Shehab TM, Orrego M, Chunduri R, Lok AS.  Identification and management of hepatitis C patients in primary care clinics. Am J Gastroenterol. 2003 Mar;98(3):639-44.

7264.   Shim YH, Yoon GS, Choi HJ, Chung YH, Yu E.  p16 Hypermethylation in the early stage of hepatitis B virus-associated hepatocarcinogenesis. Cancer Lett. 2003 Feb 20;190(2):213-9.

7265.   Sorvillo F, Mazziotti G, Carbone A, Morisco F, Cioffi M, Rotondi M, Stornaiuolo G, Amato G, Gaeta GB, Caporaso N, Carella C.  Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis. Clin Endocrinol (Oxf). 2003 Feb;58(2):207-12.

7266.   Van Thiel DH, George M, Brems J, Holt D, Zhu Q, Edelstein S, Amiral J, Tarasuk G, Leone N.  Antiphospholipid antibodies before and after liver transplantation. Am J Gastroenterol. 2003 Feb;98(2):460-5.

7267.   Vecchi M, Folli C, Donato MF, Formenti S, Arosio E, de Franchis R.  High rate of positive anti-tissue transglutaminase antibodies in chronic liver disease. Role of liver decompensation and of the antigen source. Scand J Gastroenterol. 2003 Jan;38(1):50-4.

7268.   Velazquez RF, Rodriguez M, Navascues CA, Linares A, Perez R, Sotorrios NG, Martinez I, Rodrigo L.  Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis. Hepatology. 2003 Mar;37(3):520-7.

7269.   Yuce A, Kocak N, Demir H, Gurakan F, Ozen H, Saltik IN, Ozcay F.  Evaluation of diagnostic parameters of Wilson's disease in childhood. Indian J Gastroenterol. 2003 Jan-Feb;22(1):4-6.

7270.   Zech B, Kurtenbach A, Krieger N, Strand D, Blencke S, Morbitzer M, Salassidis K, Cotten M, Wissing J, Obert S, Bartenschlager R, Herget T, Daub H.   Identification and characterization of amphiphysin II as a novel cellular interaction partner of the hepatitis C virus NS5A protein. J Gen Virol. 2003 Mar;84(Pt 3):555-60.

  Pathogenesis:

7271.   Gaud U, Langer B, Petropoulou T, Thomas HC, Karayiannis P.  Changes in hypervariable region 1 of the envelope 2 glycoprotein of hepatitis C virus in children and adults with humoral immune defects. J Med Virol. 2003 Mar;69(3):350-6.

7272.   Geier A, Dietrich CG, Gartung C.  Antiviral therapy in HBe-Ag-positive hepatitis B with normal aminotransferase levels. Hepatology. 2003 Mar;37(3):712-3

7273.   Hu Y, Shahidi A, Park S, Guilfoyle D, Hirshfield I.  Detection of extrahepatic hepatitis C virus replication by a novel, highly sensitive, single-tube nested polymerase chain reaction. Am J Clin Pathol. 2003 Jan;119(1):95-100.

7274.   Ma SP, Sakugawa H, Makino Y, Tadano M, Kinjo F, Saito A.   The complete genomic sequence of hepatitis delta virus genotype IIb prevalent in Okinawa, Japan. J Gen Virol. 2003 Feb;84(Pt 2):461-4.

7275.   Okamoto N, Yotsuyanagi H, Ooka S, Matsui T, Suzuki Kurokawa M, Suzuki M, Iino S, Nishioka K, Kato T.  Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapy. Intervirology. 2003;46(1):56-65.

7276.   Pasquier C, Bujan L, Daudin M, Righi L, Berges L, Thauvin L, Berrebi A, Massip P, Puel J, Izopet J.   Intermittent detection of hepatitis C virus (HCV) in semen from men with human immunodeficiency virus type 1 (HIV-1) and HCV. J Med Virol. 2003 Mar;69(3):344-9.

7277.   Santamaria E, Avila MA, Latasa MU, Rubio A, Martin-Duce A, Lu SC, Mato JM, Corrales FJ.  Functional proteomics of nonalcoholic steatohepatitis: mitochondrial proteins as targets of S-adenosylmethionine. Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3065-70.

7278.   Wong RH, Yeh CY, Hsueh YM, Wang JD, Lei YC, Cheng TJ.   Association of hepatitis virus infection, alcohol consumption and plasma vitamin A levels with urinary 8-hydroxydeoxyguanosine in chemical workers. Mutat Res. 2003 Mar 3;535(2):181-6.

Vaccines:

7279.   Williams IT, Goldstein ST, Tufa J, Tauillii S, Margolis HS, Mahoney FJ.  Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination. Pediatr Infect Dis J. 2003 Feb;22(2):157-63.

Therapy:

7280.   Chen LK, Hwang SJ, Tsai ST, Luo JC, Lee SD, Chang FY.  Glucose intolerance in Chinese patients with chronic hepatitis C. World J Gastroenterol. 2003 Mar;9(3):505-8.

7281.   Gonzalez-Candelas F, Bracho MA, Moya A.  Molecular epidemiology and forensic genetics: application to a hepatitis C virus transmission event at a hemodialysis unit. J Infect Dis. 2003 Feb 1;187(3):352-8.

7282.   Ji X, Cheung R, Cooper S, Li Q, Greenberg HB, He XS.  Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C. Hepatology. 2003 Mar;37(3):610-21.

7283.   Kapadia SB, Brideau-Andersen A, Chisari FV.   Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):2014-8.

7284.   Setchell KD, Heubi JE, Bove KE, O'Connell NC, Brewsaugh T, Steinberg SJ, Moser A, Squires RH Jr.   Liver disease caused by failure to racemize trihydroxycholestanoic acid: gene mutation and effect of bile acid therapy. Gastroenterology. 2003 Jan;124(1):217-32.